Elena Bonazzoli - Dissemin

Language
Login

All papers authored by Elena Bonazzoli

This paper is made freely available by the publisher.

2020 Burak Zeybek, Aranzazu Manzano, Anna Bianchi, Elena Bonazzoli

ORCID

, Stefania Bellone, Natalia Buza, Pei Hui, Salvatore Lopez

ORCID

, Paola Manara, Emanuele Perrone, Gary Altwerger, Luca Zammataro, Chanhee Han, Joan R. Tymon-Rosario, Gulden Menderes and 6 other authors

Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2018 Chanhee Han, Stefania Bellone, Eric R. Siegel, Gary Altwerger, Gulden Menderes, Elena Bonazzoli

ORCID

, Tomomi Egawa-Takata, Francesca Pettinella, Anna Bianchi, Francesco Riccio, Luca Zammataro, Ghanshyam Yadav

ORCID

, Jarrod A. Marto, Marie-France Penet, Douglas A. Levine and 9 other authors

A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

2017 Gulden Menderes, Elena Bonazzoli

ORCID

, Stefania Bellone, Gary Altwerger, Jonathan D. Black, Katherine Dugan, Francesca Pettinella, Alice Masserdotti, Francesco Riccio, Anna Bianchi, Luca Zammataro, Christopher de Haydu, Natalia Buza, Pei Hui, Serena Wong and 7 other authors

Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression

Upload

This paper is made freely available by the publisher.

Gulden Menderes, Elena Bonazzoli

ORCID

, Stefania Bellone, Jonathan Black, Gary Altwerger, Alice Masserdotti, Francesca Pettinella, Luca Zammataro, Natalia Buza, Pei Hui, Serena Wong, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang

ORCID

and 3 other authors

SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression

Download from doi.org

Missing publications? Search for publications with a matching author name.